Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

A Visit to Arctic Pharma in Oslo, Norway

Posted on October 16th, 2017 by in Pharma R&D

In Norway, a land that evokes images of rough-hewn Scandinavians, icy natural beauty and old wooden Viking ships, there is in fact a great deal of investment currently being put into not-so-rugged things like cutting-edge new labs and state-of-the-art scientific research.

Continue reading “A Visit to Arctic Pharma in Oslo, Norway” »

Snakes (aka Chutes) and Ladders – failures and opportunities

Posted on October 13th, 2017 by in Pharma R&D

If there ever was a children’s game that would help prepare the next generation of pharmaceutical R&D scientists and researchers, it would be Snakes and Ladders (Chutes and Ladders in the US). Continue reading “Snakes (aka Chutes) and Ladders – failures and opportunities” »

From mega-merger to big bang?

Posted on October 3rd, 2017 by in Pharma R&D

It was not so long ago that there was a perception that the biopharma industry was consolidating and becoming leaner and more focused in its operations, moving to a regional hotspot model Continue reading “From mega-merger to big bang?” »

Is the Pharma Industry Missing the Big Picture?

Posted on September 22nd, 2017 by in Pharma R&D

There is a disconnect between how drugs are developed and how they are used. In the traditional method of target-oriented development, each new candidate drug is scrutinized in a handful of interactions with desirable and undesirable targets. Continue reading “Is the Pharma Industry Missing the Big Picture?” »

  1. 1
  2. 2
  3. 3
  4. 8